US EditionUK to offer to pay more for some drugs to appease Trump, FT reports
The UK aims to ease US tariff threats by increasing National Health Service drug payments amid disputes over high American drug prices, with key negotiations planned next week.
- On September 26, the British government announced plans to increase its spending on medicines purchased for the National Health Service in response to US tariff threats.
- The move followed US President Donald Trump's threat of 100 percent tariffs on drugmakers unless they build US manufacturing sites and lower prices by September 29.
- Leading pharmaceutical companies from the UK, including AstraZeneca and GlaxoSmithKline, have established production sites in the United States and continue to commit to further investments, while the UK government maintains ongoing constructive discussions with both US authorities and the industry.
- A British government spokesperson emphasized their commitment to prioritizing the interests of patients and taxpayers while working to foster innovation and ensure cost-effectiveness during ongoing discussions.
- The British offer and dialogue aim to ease tensions over pharmaceutical tariffs and high US drug prices that President Trump has repeatedly criticized.
7 Articles
7 Articles
UK to offer to pay more for some drugs to appease Trump, FT reports
The British government will offer to pay more for medicines that it buys for the National Health Service, the Financial Times reported on Friday, hoping to defuse one of U.S. President Donald Trump's top complaints after he announced steep tariff increases on branded medication.
UK set to pay more for NHS drugs to appease Trump: report
The British government will offer to pay more for medicines that it buys for the National Health Service, the Financial Times reported on Friday, hoping to defuse one of US President Donald Trump’s top complaints after he announced steep tariff increases on branded medication.Prime Minister Keir Starmer’s chief business adviser, Varun Chandra, will travel to Washington next week to discuss the offer, the report added.The president has fumed beca…
Coverage Details
Bias Distribution
- 83% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
